Related Experiment Video
Updated: May 11, 2026
07:44
Analysis of Fatty Acid Content and Composition in Microalgae
Published on: October 1, 2013
59.8K
Comparative Analysis of Fatty Acid Bioaccessibility in Commercial Marine Oil Supplements: An In Vitro Integrated
Thomas Montebugnoli1, Giorgia Antonelli1, Elena Babini1,2
1Department of Agricultural and Food Sciences (DISTAL), University of Bologna, 47521 Cesena, Italy.
Foods (Basel, Switzerland)
|January 8, 2025
Summary
Marine oil supplements from krill and Calanus finmarchicus show varying fatty acid release due to lipid class differences. This impacts the absorption and efficacy of essential omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs).
Area of Science:
- Nutritional Science
- Marine Biology
- Biochemistry
Background:
- Marine oil supplements aim to increase intake of omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs).
- Lipid class distribution in oils from different marine sources (fish, krill, zooplankton) affects fatty acid bioaccessibility.
- Understanding fatty acid release is crucial for optimizing supplement efficacy.
Purpose of the Study:
- To evaluate and compare the in vitro release of free fatty acids (FFAs) from various marine oil supplements.
- To investigate the influence of oil source and lipid composition on fatty acid bioaccessibility.
- To correlate FFA release with potential absorption and efficacy of n-3 LC-PUFAs.
Main Methods:
- In vitro digestion of four commercial marine oil supplements (fish, krill, Calanus finmarchicus).
- Analysis of fatty acid release using Thin-Layer Chromatography with Flame Ionization Detection (TLC-FID).
- Structural elucidation of lipid classes and fatty acid distribution using proton Nuclear Magnetic Resonance (¹H-NMR) spectroscopy.
Main Results:
- FFA release after simulated digestion varied significantly based on the marine oil source.
- Calanus oils, rich in wax esters, exhibited the lowest FFA release.
- Lipid partitioning into different classes, rather than encapsulation, was the primary determinant of FFA release.
Conclusions:
- The source of marine oil and its lipid class composition critically influence n-3 LC-PUFA bioaccessibility.
- Lower FFA release from certain oils (e.g., Calanus) may impact the absorption and efficacy of omega-3s.
- These findings may help explain inconsistencies observed in clinical studies using marine oil supplements.
Related Concept Videos
01:28Overview of Fatty Acid Metabolism
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
01:16Methods for Studying Drug Absorption: In vitro
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
01:22Bioavailability: Influencing Factors
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
01:27Bioavailability Study Design: Absolute Versus Relative Bioavailability
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...